3-Ethyl-4-phenyl-4-thiazolin-2-thion | 55976-02-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-Ethyl-4-phenyl-4-thiazolin-2-thion
• 英文别名: 4-Phenyl-3-aethyl-2-thioxo-Δ⁴-thiazolin；3-ethyl-4-phenyl-3H-thiazole-2-thione；3-Aethyl-4-phenyl-3H-thiazol-2-thion；2(3H)-Thiazolethione, 3-ethyl-4-phenyl-；3-ethyl-4-phenyl-1,3-thiazole-2-thione
• CAS: 55976-02-8
• 化学式: C₁₁H₁₁NS₂
• 分子量: 221.347
• InChiKey: PZHPVNNBZFFIQF-UHFFFAOYSA-N

物化性质

• 熔点：
  84 °C
• 沸点：
  345.1±45.0 °C(Predicted)
• 密度：
  1.28±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  60.6
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-Ethyl-4-phenyl-4-thiazolin-2-thion 在 重水 、 lithium diisopropyl amide 作用下， 生成 5-deuterio-3-ethyl-4-phenyl-1,3-thiazole-2-thione
  参考文献：
  名称：

  Synthesis of 3,4,5-Trisubstituted-2(3H)-thiazolethiones via Metallation of 3,4-Disubstituted-2(3H)-thiazolethiones

  摘要：

  DOI：

  10.1055/s-1980-29208
• 作为产物：
  描述：

  苯甲酰氯 在 potassium tert-butylate 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 15.0h， 生成 3-Ethyl-4-phenyl-4-thiazolin-2-thion
  参考文献：
  名称：

  CS2、胺和氧化亚硝叶立德在水中的多组分反应：直接获得 β-酮基二硫代氨基甲酸酯、噻唑烷-2-硫酮和噻唑-2-硫酮

  摘要：

  已经描述了通过 CS 2 、胺和氧化硫叶立德的多组分反应合成 β-酮基二硫代氨基甲酸酯、噻唑烷-2-硫酮和噻唑-2-硫酮的简单、通用且无催化剂的合成方法。β-酮基亚砜叶立德在 CS 2和仲胺存在下生成 β-酮基二硫代氨基甲酸酯，而伯胺在酸性环境中脱水后生成噻唑烷-2-硫酮或噻唑-2-硫酮。反应过程简单，底物范围广，官能团耐受性好。

  DOI：

  10.1021/acs.joc.2c02763

文献信息

• [EN] METHODS AND COMPOSITIONS TO MODIFY GSK-3 ACTIVITY<br/>[FR] PROCÉDÉS ET COMPOSITIONS POUR MODIFIER L'ACTIVITÉ DE GSK-3
  申请人：UNIV OHIO

  公开号：WO2016010611A1

  公开（公告）日：2016-01-21

  Methods for modulating GSK-3 activity and methods for treating a GSK-3 -mediated disorder in a subject in need thereof. The methods include contacting a cell expressing GSK-3 with or administering to the subject in need a therapeutically effective amount of one or more compounds of General Formula (I) or General Formula (II): or pharmaceutically-acceptable salts or solvates thereof.

  调节GSK-3活性的方法和治疗需要的主体中GSK-3介导的疾病的方法。该方法包括将表达GSK-3的细胞与或向需要的主体施用一种或多种通用式(I)或通用式(II)的化合物的治疗有效量接触，或其药用接受的盐或溶剂。
• Imidazole and thiazole compositions for modifying biological signaling
  申请人：Ohio University

  公开号：US10023567B2

  公开（公告）日：2018-07-17

  Compounds having General Formula (I) or General Formula (II): in which R1 is chosen from C1 to C10 aliphatic or heteroaliphatic groups, optionally substituted with one or more aryl groups, substituted aryl groups, heteroaryl groups, substituted heteroaryl groups, or combination thereof; R2 is chosen from aromatic moieties, substituted aromatic moieties, heteroaromatic moieties substituted heteroaromatic moieties, and coumarin; R3 is chosen from —H, C1 to C10 aliphatic or heteroaliphatic groups, phenyl, or substituted phenyl, wherein the aliphatic or heteroaliphatic groups are optionally substituted with one or more phenyl groups, aryl groups, heteroaryl groups, substituted heteroaryl groups, or combination thereof, and wherein the aliphatic or heteroaliphatic groups are optionally bonded to R2 to form a ring; X is S or O; and Y is S or NH, may be used in pharmaceutical compositions that modify of biological signaling processes or as reagents for biological assays.

  具有通式(I)或通式(II)的化合物：其中 R1 选自 C1 至 C10 脂肪族或杂脂肪族基团，任选被一个或多个芳基、取代芳基、杂芳基、取代杂芳基或其组合取代；R2 选自芳香族基团、取代芳香族基团、杂芳香族基团、取代杂芳香族基团和香豆素；R3 选自-H、C1 至 C10 脂肪族或杂脂肪族基团、苯基或取代苯基，其中脂肪族或杂脂肪族基团可选择被一个或多个苯基、芳基、杂芳基、取代杂芳基或其组合取代，并且其中脂肪族或杂脂肪族基团可选择与 R2 键合形成环；X 是 S 或 O；Y 是 S 或 NH，可用于改变生物信号转导过程的药物组合物或用作生物检测试剂。
• Hirano, Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1956, vol. 76, p. 1153,1155
  作者：Hirano

  DOI：——

  日期：——
• KOROHODA, M. J., POL. J. CHEM., 1983, 57, N 7-9, 875-880
  作者：KOROHODA, M. J.

  DOI：——

  日期：——
• IMIDAZOLE AND THIAZOLE COMPOSITIONS FOR MODIFYING BIOLOGICAL SIGNALING
  申请人：Ohio University

  公开号：US20170210737A1

  公开（公告）日：2017-07-27

  Compounds having General Formula (I) or General Formula (II): in which R 1 is chosen from C 1 to C 10 aliphatic or heteroaliphatic groups, optionally substituted with one or more aryl groups, substituted aryl groups, heteroaryl groups, substituted heteroaryl groups, or combination thereof; R 2 is chosen from aromatic moieties, substituted aromatic moieties, heteroaromatic moieties substituted heteroaromatic moieties, and coumarin; R 3 is chosen from —H, C 1 to C 10 aliphatic or heteroaliphatic groups, phenyl, or substituted phenyl, wherein the aliphatic or heteroaliphatic groups are optionally substituted with one or more phenyl groups, aryl groups, heteroaryl groups, substituted heteroaryl groups, or combination thereof, and wherein the aliphatic or heteroaliphatic groups are optionally bonded to R 2 to form a ring; X is S or O; and Y is S or NH, may be used in pharmaceutical compositions that modify of biological signaling processes or as reagents for biological assays.